Successful treatment of primary advanced gastric plasmacytoma using a combination of surgical resection and chemotherapy with bortezomib: A case report

Autor: Toshihiro Nishida, Hideharu Okanobu, Sotaro Fukuhara, Toshiro Takafuta, Michiko Kida, Miki Kido, Hirofumi Tazawa, Hideki Ohdan, Hideto Sakimoto
Rok vydání: 2016
Předmět:
Surgical resection
endocrine system
medicine.medical_specialty
Auto-PBSCT
autologous peripheral blood stem-cell transplantation

medicine.medical_treatment
Case Report
VCD
bortezomib
cyclophosphamide
and dexamethasone

03 medical and health sciences
0302 clinical medicine
immune system diseases
PET-CT
positron emission tomography-CT

hemic and lymphatic diseases
medicine
Chemotherapy
neoplasms
PET-CT
Bortezomib
business.industry
Stomach
EMP
extramedullary plasmacytoma

Plasma cell neoplasm
medicine.disease
CT
computed tomography

Surgery
medicine.anatomical_structure
VD
bortezomib and dexamethasone

030220 oncology & carcinogenesis
FDG
fludeoxyglucose (18F)

ESD
endoscopic submucosal dissection

Plasmacytoma
030211 gastroenterology & hepatology
Extramedullary plasmacytoma
Radiology
business
medicine.drug
Zdroj: International Journal of Surgery Case Reports
ISSN: 2210-2612
DOI: 10.1016/j.ijscr.2016.08.041
Popis: Highlights • No general treatment guidelines have been established for gastricplasmacytoma. • Combination therapy with chemotherapy involving bortezomib and autologous peripheral blood stem-cell transplantation after the resection could be one of the useful options for the advanced gastricplasmacytoma.
Introduction Extramedullary plasmacytoma (EMP) is a plasma cell neoplasm that presents as a solitary tumor. EMP in the gastrointestinal organs are extremely uncommon. Presentation of case A 36-year-old man was admitted to our hospital with advanced anemia. He had no specific medical history. Gastroendoscopic findings showed an 8.0-cm submucosal tumor with ulcer on the greater curvature of the gastric body. Fine-needle aspiration was performed, and the pathologic diagnosis of the submucosal tumor was a plasmacytoma. Therefore, the patient was diagnosed with gastric plasmacytoma. A total gastrectomy was performed with lymphadenectomy. The result of intraoperative peritoneal lavage cytology was positive. Histological examination revealed serosa-exposed plasmacytoma of the stomach with lymph nodes metastasis. Additionaly the patient received a three-drug chemotherapy regimen (bortezomib, cyclophosphamide, and dexamethasone [VCD]) from 3 weeks after the operation. After 4 cycles of chemotherapy, the patient received autologous peripheral blood stem-cell transplantation (auto-PBSCT). Eighteen months after diagnosis, the patient is in complete remission with no evidence of local relapse or evolution to multiple myeloma. Conclusions This is the first reported case of advanced gastric plasmacytoma using adjuvant chemotherapy involving bortezomib and auto-PBSCT after the resection, and the patient has maintained a good course over a year. This protocol could be a new way to treat these tumors.
Databáze: OpenAIRE